ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,233, issued on July 29, was assigned to MAPI PHARMA LTD. (Ness Ziona, Israel).
"Depot systems comprising glatiramer acetate" was invented by Ehud Marom (Tel Aviv, Israel), Nadav Bleich Kimelman (Tel Aviv, Israel), Uri Danon (Tel Aviv, Israel) and Shai Rubnov (Tel Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods of use thereof for treating or ameliorating multiple sclerosis (MS) by administering a depot formulation comprising 40 mg glatiramer acetate intramuscularly to the MS patient."
The patent was filed on Aug. 9, 2017, under Application No. 16/328,582.
*For further information, ...